<DOC>
	<DOCNO>NCT00414934</DOCNO>
	<brief_summary>18F ion positron emit bone radiopharmaceutical . The skeletal uptake 18F relies exchange hydroxyl ion hydroxyapatit crystal indicator bone metabolic activity ( 8 ) . It good soft tissue clearance high affinity bone matrix . It able perform highly sensitive whole-body screen bone metastasis use high resolution PET scanner . Therefore , conduct prospective study evaluate accuracy clinical value 18F PET stag bone metastases 1 . Comparing sensitivity 18F-NaF PET 99mTc-MDP scintigraphy ; 2 . Determining clinical impact PET result subsequent patient management .</brief_summary>
	<brief_title>18F-NaF PET Detecting Metastatic Bone Lesion Patients With Cancer .</brief_title>
	<detailed_description>Skeletal metastasis common cause morbidity mortality patient malignancy , especially patient breast cancer , lung cancer , prostate cancer head &amp; neck cancer . In patient lung cancer , bone metastasis present 20-30 % patient initial diagnosis ( 1-2 ) . Accuracy stag bone metastasis lead modification follow treatment evaluation prognosis . The planar whole-body 99mTc-methylene diphosphonate ( MDP ) radionuclide bone scintigraphy widely use technique detect metastatic bone lesion present . Abnormal tracer accumulation may occur skeletal site elevate rate bone turnover . However , conventional planar bone scintigraphy report less sensitive MRI detect spinal metastasis ( 3-7 ) . 18F ion positron emit bone radiopharmaceutical . The skeletal uptake 18F relies exchange hydroxyl ion hydroxyapatit crystal indicator bone metabolic activity ( 8 ) . It good soft tissue clearance high affinity bone matrix . It able perform highly sensitive whole-body screen bone metastasis use high resolution PET scanner . To best knowledge , limited study evaluate clinical utilization 18F-NaF PET detection bone metastasis ( 10-12 ) . Therefore , would like conduct prospective study evaluate accuracy clinical value 18F PET stag bone metastases 1 . Comparing sensitivity 18F-NaF PET 99mTc-MDP scintigraphy ; 2 . Determining clinical impact PET result subsequent patient management . 99mTc-MDP scintigraphy 18F PET perform 2 week patient . Interpretation 99mTc-MDP scintigraphy 18F PET perform follow criterion describe Crasnow et ( 13 ) . The accuracy 99mTc-MDP scintigraphy 18F PET detection bone metastases patient determined histopathological result , MRI result , clinical evidence afterward .</detailed_description>
	<criteria>pathology proofed lung cancer refer perform wholebody bone scintigraphies stag metastatic bone diseases patient whose age 18 pregnant woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>cancer</keyword>
	<keyword>bone scan</keyword>
	<keyword>NaF bone PET</keyword>
</DOC>